For decades, cancer treatment has relied on surgery, chemotherapy, and radiation. While effective, these approaches often come with significant side effects and limitations. In recent years, immunotherapy, especially CAR-T cell therapy, has transformed outcomes for certain cancers. But now, a breakthrough could push the field even further.
Scientists have developed a method to engineer cancer-fighting immune cells directly inside the patient’s body, potentially eliminating the need for complex laboratory procedures.
This innovation is being described as one of the most promising advancements in modern oncology.
Confused about treatment options?
Get a free second opinion from our oncologists
CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is a personalised cancer treatment that modifies a patient’s immune system to target cancer cells.
How Traditional CAR-T Therapy Works
Once inside the body, these engineered T cells identify and destroy cancer cells.
Proven Success
CAR-T therapy has shown remarkable results in:
In some cases, patients with no other options have achieved long-term remission.
Despite its success, CAR-T therapy faces critical challenges:
Extremely High Cost
Treatment can cost $400,000+, making it inaccessible for many patients globally.
Complex Manufacturing Process
Limited Availability
Only a few advanced centers worldwide can offer this therapy.
Not Effective for All Cancers
Safety Concerns
These barriers highlight the need for a simpler, scalable alternative.
Researchers from the University of California, San Francisco (UCSF), along with collaborating institutions, have developed a novel approach to generate CAR-T cells inside the body (in vivo).
Instead of extracting and modifying cells externally, this approach:
This eliminates the need for lab-based cell engineering.
The innovation relies on targeted gene delivery systems.
Step-by-Step Mechanism
Why This Is Revolutionary
The study, published in Nature, demonstrates a highly precise gene-editing strategy.
Key Scientific Innovations
This level of precision is critical for safety and long-term effectiveness.
Preclinical studies (animal models) showed highly promising outcomes:
Blood Cancers
Solid Tumours
Speed of Response
Performance Comparison
This innovation could address several major challenges in cancer care, including:
Removing lab manufacturing could dramatically reduce treatment costs.
Patients could receive therapy within days instead of weeks.
Hospitals without advanced biotech labs could offer treatment.
Improved Patient Experience
Scalability
This method could bring advanced immunotherapy to millions of patients worldwide.
Safety remains a critical consideration.
Potential Risks
What Researchers Are Doing
Currently, this therapy is not yet available for patients.
Current Status
However, traditional CAR-T therapy is available in:
CancerRounds can help patients explore these options globally.
This breakthrough signals a shift toward:
In Vivo Therapies
Treatments created inside the body rather than in labs.
Personalised Medicine at Scale
Tailored therapies without complex infrastructure.
Expansion to More Cancers
Including solid tumours like:
Combination Therapies
Pairing in vivo CAR-T with:
Many scientists believe this innovation could:
If successful in humans, this could become one of the most important milestones in oncology.
The ability to create cancer-fighting cells directly inside the body represents a paradigm shift in medicine.
While more research is needed, this innovation has the potential to:
For patients and families navigating cancer, this breakthrough offers something invaluable: hope backed by science.
.webp){kind=logo}
Primary Study (Nature Journal):
Nyberg W., Bernard P.L., et al. (2026)
In vivo generation of CAR-T cells for cancer therapy
Published in Nature
Institutional Source:
University of California, San Francisco (UCSF)
Get expert guidance instantly
Tell us about your condition and we will help you find the right care.
Get expert guidance instantly
Share a few details and our medical team gets back to you within 4 hours with the next steps.
Tell us what you are facing and our medical team will guide you to the right doctors, hospitals and treatment.
Free Review, No Commitment
Free assessment with no pressure to proceed.
Trusted by 100,000+ Patients
Across 125+ countries worldwide
500+ Top Partner Hospitals
Globally accredited medical facilities
5000+ Expert Specialists
Senior doctors across major specialties.
Making quality healthcare accessible to patients worldwide
Everything you need to know about choosing the right hospital, doctor and treatment plan.